Maridebart Cafraglutide
MARITIME-PEN
Amgen · Phase 3 · Not yet recruiting · Enrollment 230
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart cafraglutide | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Maridebart Cafraglutide
Amgen · Phase 3 · Not yet recruiting · Enrollment 230
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Maridebart cafraglutide | Obesity or overweight | n/r | n/r | n/r | n/r |